CD163 and gastric cancer: Findings in this study also found that, CD163 expression in gastric cancer was significantly higher than that in marginal tissues, and the expression of HP-positive CD163 (75.38%) in gastric cancer was also higher than that in HP-negative tissues (52.00%).